Frank Yocca Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity
Frank Yocca is Chief Scientific Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 14,203 shares of BTAI, which is worth approximately $9,089. The most recent transaction as insider was on Sep 16, 2024, when has been sold 355 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14.2K
5.41%
3M change
34.78%
12M change
Total Value Held
$9,089
Frank Yocca Transaction History
FY
Frank Yocca
Chief Scientific Officer
New Haven, CT